Liposomes, nano-sized artificial vesicles that can be loaded with drugs, when modified with IL-13, effectively deliver drugs to malignant glioma cells, showing superior efficacy compared to non-targeted delivery [52,53]. Here, IL13 is linked to malignant glioma.